Abscess - Ithumbahttps://en.wikipedia.org/wiki/Abscess
Ithumba (Abscess) iqoqo lobu obuvuka ngaphakathi kwezicubu zomzimba. Izimpawu ze-ithumba zihlanganisa ubomvu, ubuhlungu, ukufudumala, nokuvuvukala. Ukuvuvukala kungase kuzwakale njengokugcwala uketshezi lapho ucindezelwa. Indawo ebomvu ivame ukudlulela endaweni evuvukalayo.

Ngokuvamile, amathumba avame ukubangelwa ukutheleleka kwebhaktheriya. Ibhaktheriya evame kakhulu ebangela ithumba i‑Staphylococcus aureus, evame ukumelana ne‑methicillin. Ukuxilongwa kwethumba lesikhumba kuvame ukwenziwa ngokubuka ubuso balo, futhi kuqinisekiswa ngokuhlola ukuthi livulekile yini. I‑Ultrasound imaging ingasiza ezimweni lapho ukuxilongwa kungacacile. Emathumbeni amakhulu, i‑computer tomography (CT) ingasiza ukubona ukutheleleka okujulile.

Ukwelashwa okujwayelekile kwethumba lesikhumba noma amathumba ezicubu ezithambile kuwukuwuvula ukuze kukhishwe uketshezi, kanyekanye nokusebenzisa ama‑antibiotics. Ukumunca ubomvu nge‑needle ngokuvamile akwanele.

Amathumba esikhumba ajwayelekile ayanda eminyakeni yamuva. Izinto eziyingozi zihlanganisa ukusetshenziswa kwezidakamizwa ngokufakwa emathanjeni, lapho izinga lokubika lifinyelela ku‑65 % phakathi kwabasebenzisi. Ngo‑2005 e‑United States, abantu abayizigidi ezingu‑3.2 babhekela umnyango wezimo eziphuthumayo ukuze bathole ithumba. E‑Australia, cishe abantu abayi‑13 000 balashwa esibhedlela ngo‑2008 ngenxa yalesi simo.

Ukwelashwa
Ukwelapha amathumba ngemithi ethengwayo kunzima ezimeni eziningi. Uma izimpawu ezinjengomkhuhlane nokugula zivela kuwo wonke umzimba, sicela uthintane nodokotela ngokushesha ngangokunokwenzeka.

☆ AI Dermatology — Free Service
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • i‑epidermal cyst evuthayo. Indawo emnyama ixhunywe ne‑cyst engaphansi kwesikhumba.
  • Kulesi simo sokuvuvukala kwezihlathi, kungase futhi kucatshangelwe ukuthi kukhona i-cyst epidermal.
  • Ifomu elinzima le-Ithumba (Abscess) lingashiya isibazi. I-erythema encane ezungeze isilonda ibonisa ukuthi ukutheleleka kusezingeni lokuxazululeka.
  • Ithumba (Abscess) – ezinsukwini ezinhlanu emva kokusikwa nokukhipha amanzi
  • Ichashaza elimnyama engxenyeni engenhla yethumba liphakamisa ukuthi i-epidermal cyst.
References Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Abantu abaningi baya emagumbini aphuthumayo ukuze bathole ukwelashwa kwezifo zesikhumba ezibangelwa amagciwane. Staphylococcus aureus igciwane eliyinhloko elidala lezi zifo, futhi kuyoba nzima ukuyelapha ngenxa yokuvela kwe‑community-associated methicillin-resistant Staphylococcus aureus (MRSA).
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus ingahlukaniswa ngezinhlobo ezimbili ngokuya ngempendulo yazo kuma‑antibiotics: methicillin‑sensitive Staphylococcus aureus (MSSA) and methicillin‑resistant Staphylococcus aureus (MRSA). Emashumini ambalwa eminyaka edlule, ngenxa yokwanda kwamagciwane kanye nokusetshenziswa ngokweqile kwama‑antibiotics, ukumelana kwe‑S. aureus nezidakamizwa bekhuphuka, okuholela ekwenyukeni kwamazinga okutheleleka nge‑MRSA emhlabeni wonke.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.